IT IS PROPOSED THAT AN EYE DROP DELIVERY SYSTEM WHOSE DESIRED FEATURES HAVE BEEN DEMONSTRATED BY AN OPERATIONAL MODEL BE DEVELOPED INTO A PRODUCTION PROTOTYPE THAT CAN BE MANUFACTURED AS A FINISHED PRODUCT, EXCLUSIVE OF CONTENTS, FOR A COST OF LESS THAN

Award Information
Agency:
Department of Health and Human Services
Branch
n/a
Amount:
$46,800.00
Award Year:
1984
Program:
SBIR
Phase:
Phase I
Contract:
n/a
Agency Tracking Number:
1447
Solicitation Year:
n/a
Solicitation Topic Code:
n/a
Solicitation Number:
n/a
Small Business Information
Alpha Group Systems
19712 Macarthur Bloulevard, Irvine, CA, 92715
Hubzone Owned:
N
Socially and Economically Disadvantaged:
N
Woman Owned:
N
Duns:
n/a
Principal Investigator:
JON C. THORSON
PRESIDENT
() -
Business Contact:
() -
Research Institution:
n/a
Abstract
IT IS PROPOSED THAT AN EYE DROP DELIVERY SYSTEM WHOSE DESIRED FEATURES HAVE BEEN DEMONSTRATED BY AN OPERATIONAL MODEL BE DEVELOPED INTO A PRODUCTION PROTOTYPE THAT CAN BE MANUFACTURED AS A FINISHED PRODUCT, EXCLUSIVE OF CONTENTS, FOR A COST OF LESS THAN $1. THE DEVICE WILL DELIVER WITHOUT REQUIRING UNUSUAL HEAD POSTURING OR EYELID MANIPULATION PRECISE MICRO- AMOUNTS OF MEDICATION DIRECTLY TO THE CORNEA. IT WILL REQUIRE MINIMAL PATIENT DEXTERITY. THE DEVICE WILL BE DISPOSABLE, NON-REFILLABLE, AND MAINTAIN ITS CONTENTS STERILE. LESS QUANTITY OF ACTIVE INGREDIENTS SHOULD BE REQUIRED TO PROVIDE THE DESIRED THERAPEUTIC EFFECT, AND NON-PRESERVED AGENTS SHOULD MAINTAIN THEIR STERILITY, THUS PROVIDING THE OPPORTUNITY TO REDUCED SIDE EFFECTS PRODUCED BY OVER MEDICATION OR PRESERVATIVES INHERENT IN PRESENT DROP DELIVERY SYSTEMS.

* information listed above is at the time of submission.

Agency Micro-sites

US Flag An Official Website of the United States Government